An edition of Drug regulation reform--oversight (1980)

Drug regulation reform--oversight

hearing before the Subcommittee on Health and the Environment of the Committee on Interstate and Foreign Commerce, House of Representatives, Ninety-sixth Congress, second session ...

Drug regulation reform--oversight
United States. Congress. House ...
Locate

My Reading Lists:

Create a new list

Check-In

×Close
Add an optional check-in date. Check-in dates are used to track yearly reading goals.
Today


Buy this book

Last edited by Ben Companjen
May 2, 2012 | History
An edition of Drug regulation reform--oversight (1980)

Drug regulation reform--oversight

hearing before the Subcommittee on Health and the Environment of the Committee on Interstate and Foreign Commerce, House of Representatives, Ninety-sixth Congress, second session ...

This edition doesn't have a description yet. Can you add one?

Publish Date
Publisher
U.S. G.P.O.
Language
English

Buy this book

Book Details


Table of Contents

v. 1. New drug approval process
v. 2. Orphan drugs

Edition Notes

Vol. 1: "Food and Drug Administration regulation of research, development, and marketing of drugs, June 25, 1980."

Vol. 2: "How can we best use our limited resources and at the same time insure safe and effective drugs to diseases which occur infrequently, June 26, 1980."

"Serial no. 96-170."

"Serial no. 96-216."

Published in
Washington
Other Titles
New drug approval process, Orphan drugs

The Physical Object

Pagination
v. ;

ID Numbers

Open Library
OL14216016M

Community Reviews (0)

Feedback?
No community reviews have been submitted for this work.

Lists

This work does not appear on any lists.

History

Download catalog record: RDF / JSON
May 2, 2012 Edited by Ben Companjen merge authors
December 3, 2010 Edited by Open Library Bot Added subjects from MARC records.
January 18, 2010 Edited by WorkBot add subjects and covers
December 11, 2009 Created by WorkBot add works page